Comparing a new heart CT scan with in-artery imaging for plaque risk
Compares a new CT scan with in-artery imaging in adults with stable angina.
Key facts
- Who runs it
- Queen Mary University of London
- Where
- London, United KingdomSee the site
- Trial code
- Registry title
- Identification of Lesion Characteristics in Coronary Plaques Using Multimodality Intravascular Imaging and Novel Photon-counting CT in Stable Angina
- Status
- Recruiting
- People taking part
- 70 people, planned
- Started
- 19 Aug 2026
- Expected to end
- 3 Apr 2029
- Type of study
- Observational
- Treatments tested
- observational study
- Record updated
- 7 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 79 with stable coronary artery disease. A recent photon-counting CT scan must show a lesion that needs more checking and may be treated with a stent (PCI).
- Age
- 18 to 79 years
- Sex
- All sexes
- Disease stage
- Stable coronary syndrome. A recent photon-counting CT angiography scan showed at least one lesion that needs more evaluation with intravascular imaging or fractional flow reserve, and PCI under IVUS guidance is considered possible.
- Earlier treatment
- No previous coronary artery bypass surgery and no previous heart transplantation.
Main reasons for not taking part
- Acute coronary syndrome within the last 3 months
- Kidney failure (eGFR <60ml/min/1.73m²)
- Decompensated heart failure, or left ventricular ejection fraction ≤30%
- Pregnancy
- Needs surgical revascularisation, or extensive coronary disease or twisting arteries that block the imaging
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Able and willing to give informed consent
- Between ages 18-79
- Patients with a stable coronary syndrome that had recent PC-CTA showing at least one lesion requiring further evaluation with intravascular imaging or fractional flow reserve and is considered suitable for PCI under IVUS guidance
Who cannot take part
- History of previous coronary artery bypass surgery
- Previous heart transplantation
- Unable to receive treatment with aspirin, heparin, or thienopyridines
- Patient that requires surgical revascularisation
- Recent acute coronary syndrome within < 3 months
- Intravenous contrast allergy
- Extensive coronary artery disease (i.e. multiple chronic total occlusions) or tortuous coronary anatomy that does not allow assessment of the coronary arteries with NIRS-IVUS imaging
- Renal failure (eGFR <60ml/min/1.73m²)
- Decompensated heart failure, or left ventricular ejection fraction ≤30%
- Age >80 years
- Unable to or unwilling to give informed consent
- Anticipated life expectancy <1 year
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 79 years old?
Where in United Kingdom
- William Harvey Research Institute, Barts and The London, Queen Mary University of LondonLondon, United KingdomContact: Ameer Hamid A Khan, MBBS BSc MScTaking people
About the trial
What the trial wants to find out
Coronary artery disease, caused by the furring up of the heart arteries by atherosclerosis, is a major cause of death in the UK. Despite existing therapies, adverse cardiovascular events remains high, especially in patients who have already had a heart attack, as some of these patients have aggressive atherosclerotic disease. If we could identify these vulnerable patients, then in wider clinical practice in the future we might be able to treat them better with new therapies that can otherwise be expensive or come with a risk of side-effects. Traditionally, the assessment of atherosclerotic disease and the identification of the plaques that will cause heart attacks is performed using invasive imaging - imaging taken by passing a wire into the arteries of the heart that has a camera on its tip. Invasive imaging, however, can be used only in patients with symptoms and has risks. Photon counting (PC) CT is a new CT system that has image quality comparable to invasive imaging and can be used in the community to examine individuals with stable angina symptoms. In this study we aim to compare how well PC-CT detects high-risk plaques compared with invasive imaging and in due course develop a platform that will expedite the analysis of CT images to allow its broad use in the clinical practice.
The group in the trial
- Patients with Chronic Coronary Syndrome
Treatment: observational study
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Next Generation Coronary Plaque Characterisation and Computation of Flow Patterns: Photon-Counting Computed Tomography Coronary Angiography Versus State-of-the-Art Multimodality Intravascular Imaging
- Plain-language title
- Comparing a new heart CT scan with in-artery imaging for plaque riskGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07864025, who can take part
- Record updated
- 7 October 2026